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Letters
The editorial executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters referring to 
published articles may be sent to the author for response, and may be sent to an expert for comment. Letters are usually published together with any 
responses or comments. The editorial executive Committee screens out discourteous, inaccurate or libellous statements and sub-edits letters before 
publication. The Committee's decision on publication is final.
Adverse effects and precautions
•	 Is	the	vaccine	safe?
•	 Should	I	avoid	it	if	I	am	allergic	to	another	medicine	 
(e.g. penicillin/pneumococcal vaccine)?
•	 Can	it	cause	paralysis?
•	 What	is	anaphylaxis?	I	vomited	after	the	vaccine.
•	 Can	someone	with	Hashimoto's	disease/pernicious	
anaemia/Guillain-Barré syndrome have the vaccine?
interactions
•	 Can	I	have	the	vaccine	while	on	my	other	medicines	 
(e.g. phenelzine/warfarin/methotrexate/goserelin)?
•	 Are	diphtheria	and	tetanus	vaccine	and	the	H1N1	
vaccine safe together?
•	 Can	my	husband	inject	himself	with	darbepoetin	the	
same day as getting his vaccine?
•	 Can	I	have	the	vaccine	if	I	had	oseltamivir	five	weeks	ago?
Pregnancy and lactation
•	 Should	I	wait	until	after	my	baby	is	born	to	have	my	vaccine?
•	 Is	it	safe	in	first	trimester/second	trimester?
•	 How	long	after	being	vaccinated	before	I	can	breastfeed	
again? 
•	 What	are	the	risks	and	benefits	of	getting	the	vaccine	
while breastfeeding?
Administration
•	 Is	the	multidose	vaccine	really	safe	to	use	when	you	are	
the second or third patient?
Constituents
•	 Can	I	receive	the	vaccine	if	I	have	an	allergy	to	egg	
protein/sodium benzoate/seafood/latex?
•	 Does	the	vaccine	contain	other	substances	such	as	
bacteria/squalene/mercury/aborted human cells or 
monkey cells?
efficacy
•	 Will	the	H1N1	strain	in	the	vaccine	be	in	next	year's	
influenza vaccine?
•	 Will	my	prednisolone	and	azathioprine	therapy	reduce	
the effect of the vaccine?
•	 My	wife	comes	in	close	contact	with	the	public	at	work;	
should she get the vaccine?
Access to vaccine
•	 Does	a	travel	medical	centre	provide	the	vaccine?
•	 When	will	a	single	dose	vial	be	available?
Access to information
•	 Can	you	send	me	the	consumer	information	leaflet?
Miscellaneous
•	 What	are	the	legal	implications	of	administering	the	
vaccine to the public if they are otherwise fit and 
healthy? 
•	 Can	you	give	me	unbiased	information	on	the	vaccine?	
The net has very misleading information.
By increasing awareness of our patients' vaccine concerns, 
health professionals are in a better position to proactively 
resolve consumer uncertainty and enhance compliance with 
the national vaccination strategy. If health professionals have 
difficulty answering questions on the vaccine, they can call 
the NPS Therapeutic Advice and Information Service (TAIS) 
on 1300 138 677.
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influenza H1N1 vaccine
editor, – We wish to comment on the New drugs section of 
Australian Prescriber in relation to H1N1 swine flu vaccine 
(Aust Prescr 2009;32:165−71). even before launch, Australian 
consumers were asking for information on the vaccine. Readers 
may be interested in the depth and variety of questions asked 
of pharmacists operating Medicines Line (funded by National 
Prescribing Service − NPS). This national consumer telephone 
hotline provides information about prescription, over-the-counter 
and complementary medicines. Most (82%) of the 85 questions 
received between August and october 2009 related to vaccine 
safety. A representative sample of the questions is shown below.
